JERUSALEM--(BUSINESS WIRE)--Mar. 9, 2016-- Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today announced the launch of the generic equivalent to Pulmicort Respules®1 (budesonide inhalation ...

Short-term budesonide transnasal nebulization effectively and safely treated patients with chronic rhinosinusitis with nasal polyps when compared with placebo, according to study results. In a double ...

Aurobindo Pharma’s wholly-owned subsidiary company, Eugia Pharma Specialities Ltd, has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Budesonide ...

Aurobindo Pharma Limited on Thursday announced that its wholly owned subsidiary company, Eugia Pharma Specialities Limited, has received final approval from the US Food & Drug Administration (USFDA) ...

Objective: To compare the pharmacokinetic profile and bioavailability of budesonide after inhalation from the Clickhaler® dry powder inhaler with the Turbuhaler® as standard. Design: Randomised, ...

PITTSBURGH, PA and WOODBURY, MN / ACCESSWIRE / July 31, 2023 / Viatris Inc. (NASDAQ:VTRS), a global healthcare company, and Kindeva Drug Delivery L.P. today announced the launch of Breyna™ ...

Perforomist (formoterol) is a brand-name drug that’s prescribed for chronic obstructive pulmonary disease (COPD) in adults. Perforomist comes as a liquid that’s inhaled with a nebulizer twice per day.

March 19, 2007 — Health Canada has approved budesonide plus formoterol fumarate dehydrate inhalation aerosol with a flexible regimen for the maintenance and rescue treatment of asthma in patients aged ...

"The global budesonide inhaler market is set for robust growth as increasing respiratory disorders and the expansion of generic alternatives drive demand for affordable, effective inhalation therapies ...

AstraZeneca today announced that the United States District Court for the District of New Jersey ruled that AstraZeneca's US Patent No. 6,598,603 ("the '603 patent"), protecting PULMICORT RESPULES in ...

HANGZHOU, China, March 17, 2025 /PRNewswire/ -- Chance Pharmaceuticals ("Chance Pharma"), a clinical-stage biotechnology company dedicated to the research and development of innovative inhalation ...

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/5rp48m/investigation) has announced the addition of the "Investigation ...